KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,196,058 | -9.4% | 350,445 | +5.1% | 3.93% | +4.1% |
| Q2 2023 | $3,527,848 | -20.7% | 333,445 | -8.3% | 3.77% | -19.7% |
| Q1 2023 | $4,448,944 | -1.5% | 363,773 | 0.0% | 4.70% | +8.5% |
| Q4 2022 | $4,514,423 | -9.8% | 363,773 | -0.8% | 4.33% | -31.6% |
| Q3 2022 | $5,007,000 | -25.5% | 366,569 | 0.0% | 6.32% | -24.8% |
| Q2 2022 | $6,719,000 | +16.8% | 366,569 | +2.5% | 8.41% | +61.7% |
| Q1 2022 | $5,751,000 | +378.9% | 357,620 | +316.8% | 5.20% | +410.6% |
| Q4 2021 | $1,201,000 | -45.6% | 85,800 | +27.0% | 1.02% | -7.9% |
| Q4 2020 | $2,207,000 | -37.7% | 67,568 | -41.6% | 1.11% | -53.9% |
| Q3 2020 | $3,543,000 | +0.5% | 115,641 | -46.5% | 2.40% | +16.4% |
| Q2 2020 | $3,524,000 | +11.0% | 216,171 | -32.2% | 2.06% | +0.2% |
| Q1 2020 | $3,174,000 | -13.4% | 318,992 | +19.7% | 2.06% | +30.8% |
| Q4 2019 | $3,665,000 | -9.3% | 266,527 | 0.0% | 1.57% | -38.6% |
| Q3 2019 | $4,043,000 | -23.0% | 266,527 | 0.0% | 2.56% | -25.1% |
| Q2 2019 | $5,248,000 | +32.4% | 266,527 | +11.6% | 3.42% | +21.1% |
| Q1 2019 | $3,964,000 | +29.7% | 238,916 | +9.7% | 2.82% | -36.6% |
| Q4 2018 | $3,057,000 | -19.0% | 217,750 | +1.0% | 4.45% | -21.3% |
| Q3 2018 | $3,774,000 | -3.8% | 215,662 | 0.0% | 5.66% | -15.6% |
| Q2 2018 | $3,925,000 | +15.9% | 215,662 | +19.4% | 6.70% | +46.0% |
| Q1 2018 | $3,386,000 | +146.8% | 180,595 | +101.4% | 4.59% | +110.4% |
| Q4 2017 | $1,372,000 | -17.8% | 89,673 | -19.7% | 2.18% | +11.4% |
| Q3 2017 | $1,670,000 | +85.8% | 111,673 | +15.5% | 1.96% | +92.0% |
| Q2 2017 | $899,000 | +20.5% | 96,673 | +14.0% | 1.02% | +14.1% |
| Q1 2017 | $746,000 | +96.8% | 84,769 | +31.8% | 0.90% | +87.2% |
| Q4 2016 | $379,000 | -5.7% | 64,300 | 0.0% | 0.48% | -14.3% |
| Q3 2016 | $402,000 | +139.3% | 64,300 | +3.7% | 0.56% | +142.6% |
| Q2 2016 | $168,000 | – | 62,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |